dendreon.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-Agent: * Disallow: /wp-content/plugins/ Disallow: /readme.html Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: | ||
Meta Tags
| Title | Leaders in Cellular Therapy | |
| Description | The future of cellular therapy, Learn how Dendreon is improving the lives of patients through our leadership in innovative science and cellular |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 75.2.114.34 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
dendreon.com Valuation
|
US$18,784,080
Last updated: 2023-05-04 02:39:39
dendreon.com has Semrush global rank of 563,472. dendreon.com has an estimated worth of US$ 18,784,080, based on its estimated Ads revenue. dendreon.com receives approximately 2,167,394 unique visitors each day. Its web server is located in United States, with IP address 75.2.114.34. According to SiteAdvisor, dendreon.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$18,784,080 |
| Daily Ads Revenue | US$17,340 |
| Monthly Ads Revenue | US$520,175 |
| Yearly Ads Revenue | US$6,242,095 |
| Daily Unique Visitors | 144,493 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| dendreon.com. | A | 360 | IP: 75.2.114.34 |
| dendreon.com. | A | 360 | IP: 99.83.156.110 |
| dendreon.com. | NS | 21600 | NS Record: dns2.cscdns.net. |
| dendreon.com. | NS | 21600 | NS Record: dns1.cscdns.net. |
| dendreon.com. | MX | 3600 | MX Record: 10 us-smtp-inbound-2.mimecast.com. |
| dendreon.com. | MX | 3600 | MX Record: 10 us-smtp-inbound-1.mimecast.com. |
| dendreon.com. | TXT | 300 | TXT Record: v=spf1 mx include:us._netblocks.mimecast.com include:spf.protection.outlook.com include:_spf.salesforce.com include:servers.mcsv.net ip4:107.0.61.193/26 ip4:107.1.80.2 ip4:107.0.61.217 ip4:107.0.61.218 ip4:174.47.56.161/27 ip4:174.47.19.161/27 ~all |
| dendreon.com. | TXT | 21600 | TXT Record: AI2HHIvhiDmWXTPxan4yg87iCDy6T0YTbg9oJqiifUpKbWNQ42N7Y9wGtxeegQs4uXjuABwSblQNPkP3sJxA0A== |
| dendreon.com. | TXT | 21600 | TXT Record: MS=ms73560717 |
| dendreon.com. | TXT | 360 | TXT Record: amazonses:x5wiGMrVXD8f64RZBhyJyDWv03LjfUDjUU0MghID9qo= |
| dendreon.com. | TXT | 300 | TXT Record: apple-domain-verification=Xk5Pur9EsSktSjra |
| dendreon.com. | TXT | 21600 | TXT Record: dnnhf26pi.azurewebsites.net |
| dendreon.com. | TXT | 3600 | TXT Record: docusign=21e78f41-969a-4f11-a882-85783ae7d7eb |
HtmlToTextCheckTime:2023-05-04 02:39:39
| Dendreon Main Menu News Contact Us About Science and Services Show submenu Cellular Therapy Manufacturing Provenge Immunotherapy Publications Careers The future of cellular therapy, delivered We’re revolutionizing medicine through our leadership in cellular technology. Learn More Improving The Lives of Patients Through innovative science & cellular therapies At Dendreon, we have a singular purpose: improving the lives of patients through innovative science and cellular therapies. We enable the future of complex cell therapies through research, development, and strategic partnerships. By leveraging innovative science that delivers unique therapies, our work helps change lives. See What Drives Us Provenge Technology PROVENGE ® (sipuleucel-T), Dendreon’s flagship innovation, was the first FDA-approved cellular immunotherapy brought to market. This groundbreaking treatment has been received by nearly 40,000 men. Learn More Cellular Therapy Manufacturing Helping companies to bring |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Tue, 26 Oct 2021 05:24:11 GMT Content-Type: text/html Content-Length: 178 Connection: keep-alive Server: nginx/1.18.0 (Ubuntu) Location: https://dendreon.com/ X-Frame-Options: SAMEORIGIN HTTP/2 200 date: Tue, 26 Oct 2021 05:24:11 GMT content-type: text/html;charset=UTF-8 server: nginx/1.18.0 (Ubuntu) vary: Accept-Encoding content-language: en x-frame-options: SAMEORIGIN |
dendreon.com Whois Information
Domain Name: DENDREON.COM Registry Domain ID: 1423494_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-07-24T05:14:35Z Creation Date: 1997-07-29T04:00:00Z Registry Expiry Date: 2022-07-28T04:00:00Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited Name Server: DNS1.CSCDNS.NET Name Server: DNS2.CSCDNS.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-14T06:29:07Z <<< |